The Hidden Epidemic: Valvular Heart Disease

---

14 million Americans live with valvular heart disease (VHD), yet it remains widely unrecognized and underfunded compared to other cardiovascular conditions.

The Reality of VHD:

VHD causes mortality rates that rival cancer and heart failure, yet receives far less attention and research funding. This disparity has real consequences for patients and families across America.

Key Statistics:

• 87% of all VHD cases in the U.S. involve aortic stenosis or mitral regurgitation

• Only 5-10% of those who could benefit from treatment actually receive it

• An estimated 1 million Americans have severe VHD that remains undiagnosed

• Mortality rates for severe untreated VHD are comparable to aggressive cancers

The Treatment Gap:

Despite the availability of life-saving treatments, most patients with VHD never receive the care they need. This gap exists due to a combination of factors including lack of awareness, limited access to screening, and insufficient education among both patients and healthcare providers.

Why This Matters:

VHD is not a rare condition—it affects millions of Americans. Left untreated, it progresses to heart failure and death. But with proper diagnosis and treatment, patients with VHD can live long, healthy lives. Closing the gap between diagnosis and treatment is HeartReach's primary mission.